Shareholders approve all proposals put forward by Board of Directors
(Thomson Reuters ONE) -
BB BIOTECH AG /
Shareholders approve all proposals put forward by Board of Directors
Processed and transmitted by Thomson Reuters.
The issuer is solely responsible for the content of this announcement.
Annual General Meeting of BB Biotech AG
All proposals put forward by the Board of Directors at the Annual General
Meeting of March 21, 2011 were approved by a vast majority of shareholders.
Shareholders voted for the Board of Directors' proposal to pay out a cash
dividend of CHF 3.20 per registered share for the 2010 financial year. The
dividend will be paid out on March 28, 2011.
Previously serving directors Prof. Dr. med. Thomas Szucs (Chairman) and Dr.
Clive Meanwell were re-elected to one-year terms of office. Shareholders also
elected Dr. Erich Hunziker as a new director. He is the Chief Financial Officer
and Deputy Head of the Corporate Executive Committee of the Roche Group. Dr.
Hunziker is retiring at the end of March 2011, after which he will concentrate
on selected directorships.
For further information:
Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht, Switzerland
Thomas Egger, Tel. +41 44 267 67 09,teg(at)bellevue.ch
www.bbbiotech.com
Company profile
BB Biotech invests in companies in the fast growing market of biotechnology and
is one of the world's largest investors in this sector with CHF 1.2 bn in assets
under management. BB Biotech is listed in Switzerland, Germany and Italy. Its
investments are focused on listed companies that are developing and
commercializing novel medical treatments and cures. BB Biotech's investment
selection process is guided by the fundamental research and analysis of
physicians and molecular biologists. Its Board of Directors has many years of
experience in industry and science.
--- End of Message ---
BB BIOTECH AG
Vordergasse 3 Schaffhausen Switzerland
WKN: AONFN3;ISIN: CH0038389992;
Media Release BB Biotech_21.03.11 (PDF):
http://hugin.info/130285/R/1498755/434301.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BB BIOTECH AG via Thomson Reuters ONE
[HUG#1498755]
Datum: 21.03.2011 - 18:06 Uhr
Sprache: Deutsch
News-ID 52620
Anzahl Zeichen: 2882
contact information:
Town:
Schaffhausen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 240 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Shareholders approve all proposals put forward by Board of Directors"
steht unter der journalistisch-redaktionellen Verantwortung von
BB BIOTECH AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
